Human CST complex protects stalled replication forks by directly blocking MRE11 degradation of nascent-strand DNA.

The EMBO Journal
Xinxing LyuWeihang Chai

Abstract

Degradation and collapse of stalled replication forks are main sources of genomic instability, yet the molecular mechanisms for protecting forks from degradation/collapse are not well understood. Here, we report that human CST (CTC1-STN1-TEN1) proteins, which form a single-stranded DNA-binding complex, localize at stalled forks and protect stalled forks from degradation by the MRE11 nuclease. CST deficiency increases MRE11 binding to stalled forks, leading to nascent-strand degradation at reversed forks and ssDNA accumulation. In addition, purified CST complex binds to 5' DNA overhangs and directly blocks MRE11 degradation in vitro, and the DNA-binding ability of CST is required for blocking MRE11-mediated nascent-strand degradation. Our results suggest that CST inhibits MRE11 binding to reversed forks, thus antagonizing excessive nascent-strand degradation. Finally, we uncover that CST complex inactivation exacerbates genome instability in BRCA2 deficient cells. Collectively, our findings identify the CST complex as an important fork protector that preserves genome integrity under replication perturbation.

References

Oct 10, 2008·Proceedings of the National Academy of Sciences of the United States of America·Kerstin GariAngelos Constantinou
Oct 12, 2010·Nature Structural & Molecular Biology·Yoshitami HashimotoVincenzo Costanzo
Oct 16, 2010·Trends in Biochemical Sciences·Rachel Litman Flynn, Lee Zou
Jun 21, 2011·Genes & Development·Bianca M SirbuDavid Cortez
Jan 24, 2012·Nature Genetics·Beverley H AndersonYanick J Crow
Apr 26, 2012·Pediatric Blood & Cancer·Rachel B KellerSuneet Agarwal
Jul 6, 2012·Nature·Liuh-Yow ChenJoachim Lingner
Apr 4, 2013·Science Signaling·Jianjiong GaoNikolaus Schultz
Apr 17, 2013·Proceedings of the National Academy of Sciences of the United States of America·Elda CannavoStephen C Kowalczykowski
Jul 5, 2013·PloS One·Christopher BryanEmmanuel Skordalakes
Oct 12, 2013·Genes & Development·Liuh-Yow ChenJoachim Lingner
Oct 5, 2014·Experimental Cell Research·Abdelghani MazouziJoanna I Loizou
Feb 26, 2015·Nature Reviews. Molecular Cell Biology·Kai J Neelsen, Massimo Lopes
Mar 4, 2015·The Journal of Cell Biology·Saravanabhavan ThangavelAlessandro Vindigni
Mar 4, 2015·The Journal of Cell Biology·Ralph ZellwegerMassimo Lopes
Jun 9, 2015·Molecular Cell·Andrew C KileKarlene A Cimprich
Apr 23, 2016·Methods : a Companion to Methods in Enzymology·Jadwiga NieminuszczyWojciech Niedzwiedz
Jul 20, 2016·The Journal of Experimental Medicine·Amos J SimonRaz Somech
Jul 23, 2016·Nature·Arnab Ray ChaudhuriAndré Nussenzweig
Jun 25, 2017·Methods in Enzymology·Annabel QuinetAlessandro Vindigni
Jul 21, 2017·Biochemistry·Robert A Hom, Deborah S Wuttke
Sep 22, 2017·Nucleic Acids Research·Swapna Ganduri, Neal F Lue
Oct 19, 2017·Nature Communications·Sofija MijicMassimo Lopes
Dec 9, 2017·Molecular Cell·Annabel QuinetAlessandro Vindigni
Feb 25, 2018·The Journal of Cell Biology·Sunetra RoyKatharina Schlacher

❮ Previous
Next ❯

Citations

Apr 20, 2021·Frontiers in Cell and Developmental Biology·Erin BonnellRaymund J Wellinger

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.